The coagulation system is frequently activated and coagulation activation markers elevated in acute ischemic stroke (1) (2) (3) (4) (5) (6) (7) (8) (9) . The magnitude of hemostatic changes in acute stroke may show the extent of cerebral damage, and also have implications for the course of disease and the effect of treatment (10) .
Chronic nonvalvular atrial fibrillation (NVAF) is an important risk factor for ischemic stroke, affected patients being at five or six times the risk of people in sinus rhythm (11, 12) . The patients with NVAF have a hypercoagulable status in association with stroke evaluation. Coagulation activation in the acute phase of the stroke may demonstrate a hypercoagulable state before the stroke, as well as an ongoing thrombotic process itself (10, 13) . To determine the rate of the activation of coagulation in patients with acute stroke may affect therapeutic management as well as outcome (10) .
We conducted this study to determine whether patients with stroke and NVAF have more abundant coagulation activation than the patients with sinus rhythm in acute period. We measured prothrombin fragment 1+2 (F1+2), D-dimer (D-D), and fibrinogen levels in the patients with acute ischemic stroke with NVAF and sinus rhythm. In addition, we evaluated whether there is a correlation between hemostatic para- Summary: The coagulation system is activated and coagulation activation markers are elevated in acute ischemic stroke with nonvalvular atrial fibrillation (NVAF). The etiology, severity, and prognosis of the ischemic stroke might be estimated with the level of the activation of the coagulation system. In this study, prothrombin F1+2 (F1+2), D-dimer, and fibrinogen levels were measured in patients with acute ischemic stroke with and without NVAF, and stroke severity was compared with these hemostatic parameters. Of 55 patients, 29 had sinus rhythm (group I), 26 had NVAF (group II); 20 healthy subjects (group III) were included in the study. Subtypes of cerebral infarction were classified. The patients underwent stroke severity, electrocardiography, echocardiography, cranial computed tomography, cervical duplex ultrasonography, and hemostatic parameter studies. In group II, F1+2 level (2.83±0.89) was significantly higher than in group I (2.33±0.80) and III (1.94±0.64) (p values: group I-II, 0.036; groups II-III, 0.001; groups I-III, 0.104). In group III, fib-rinogen level (251.64±60.96) was significantly lower than that in groups I (347.97±111.49) and II (364.04±86.20) (p=0.001). Ddimer was not significantly different between groups. In group I, lacunar syndrome (LACS), and in group II, partial and total anterior circulation syndrome (PACS+TACS) were more common (p=0.013, p=0.001, respectively). In group II, Scandinavian Stroke Scale scores were lower than those in group I (group I=45.2±14, group II=35.4±18.9, p=0.02). In conclusion, activation of coagulation, demonstrated by increment F1+2, is more abundant in the stroke patients with NVAF than in the stroke patients with sinus rhythm.
Our results also showed that activation of the hemostatic system might be related to stroke subtype and stroke severity. It is suggested that the oral anticoagulation treatment as prophylaxis is important in the prevention of stroke in patients with NVAF. meters and cardiologic findings in the stroke patients with NVAF and stroke severity in all the stroke patients.
SUBJECTS AND METHODS

Patients and Control Subjects
Fifty-five consecutive patients with acute ischemic stroke were included in the study. Twenty-nine had sinus rhythm (group I, age: 64.86±10.58), 26 had NVAF (group II, age: 67.42±11.28). NVAF was defined as evidence of atrial fibrillation on conventional electrocardiography (ECG). Patients with mitral stenosis, acute myocardial infarction, malignant disease, and those taking oral anticoagulation were excluded. At initial assessment, 20.7% of the patients in the group I and 38.5% of the patients in the group II were already receiving acetylsalicilic acid. The control group consisted of 20 gender-and agematched healthy subjects (group III, age: 65.61±10.41). The control subjects selected from the population register, and no history, physical signs, or ECG findings indicative of a previous thromboembolic event, ischemic heart disease, hypertension, atrial fibrillation, diabetes mellitus, hypercholesterolemia, malignancy, or ongoing infection. Patients in groups I and II underwent neurologic examination, identified subtypes of cerebral infarction, stroke severity, ECG, transthoracic echocardiography (TTE), cranial computed tomography (CT), cervical duplex ultrasonography, and hemostatic parameter testing. Subjects in group III underwent hemostatic parameter testing only.
Blood Analysis
Groups I and II had blood drawn at baseline for measurement of complete blood cell count, and liver, renal, and lipid profiles. We measured plasma levels of the F1+2, D-dimer, and fibrinogen in 55 patients with acute ischemic stroke within 24 hours of stroke onset before anticoagulation and 20 control subjects. Venous blood was obtained and collected in tubes with sodium citrate for measurement of F1+2, D-dimer, and fibrinogen. Platelet-poor plasma was obtained by centrifuging the blood immediately in a refrigerated centrifuge at 3000 rpm for 15 minutes. Plasma was placed in aliquots and kept at -80°C until testing. F1+2 was measured with a sandwich ELISA method (Enzygnost F1+2 micro, Dade Behring, Germany). Fibrinogen was measured with Clauss's method (Diagnostica Stago, France). D-dimer analysis was performed with a latex agglutination method (Diagnostica Stago, France), which is a qualitative method, and values at 1/8 assessed as D-dimer positive.
Identification of Subtypes of Cerebral Infarction and Stroke Severity
Cerebral infarction subtypes was identified on admission by the Oxfordshire Community Stroke Project (OCSP) classification (14) . According to this classification, patients divided as lacunar syndrome (LACS), partial anterior circulation syndrome (PACS), total anterior circulation syndrome (TACS), and posterior circulation syndrome (POCS). Stroke severity on admission was identified with use of the Scandinavian Stroke Scale (15) .
Echocardiography
The examinations were performed for each subject by using Hewlett-Packard Sonos 2500 system equipped with a 2.5-MHz transducer. Mmode measurements of LV internal diastolic (LVIDD) and systolic diameters were made on parasternal long axis view. Ejection fraction (EF) was calculated by using the Teichholz formula. Left atrial dimensions and left atrial thrombus were determined on parasternal and apical twodimensional windows. Transoesophageal examinations (TEE) were performed by using a multiplane transducer.
Statistical Methods
Statistical analyses were performed using MINITAB Ver 13.1. Non-parametric ANOVA (Kruskal-Wallis ANOVA) analysis of variance was used to test the difference between groups; subsequent pairwise comparisons were made using the Mann-Whitney-U test. A level of p<0.05 was accepted as statistically significant. Table 1 displays the distribution of the demographic characteristics and vascular risk factors of groups. Age, gender, hypertension, diabetes mellitus, and hypercholesterolemia were not significantly different between groups (p values: 0.521, 0.064, 0.385, 0.149, and 1.0, respectively).
RESULTS
Demographic Characteristics and Vascular Risk Factors
Stroke Characteristics
In group I, LACS was significantly higher than in group II (p=0.013); in group II, PACS+TACS was significantly higher than in group I (p=0.001). Silent infarction and previous stroke were not different between groups (p=0.335, p= 0.926, respectively). In group II, Scandinavian Stroke Scale scores were lower than those in group I (group I, 45.2±14; group II, 35.4±18.9; p=0.02) ( Table 2) . Table 3 shows the mean (and SD) levels of the markers across groups. In group II, F1+2 level was significantly higher than that in groups I and III (p values: groups I-II=0.036, groups II-III=0.001, groups I-III=0.104). No significant differences for D-dimer levels was found between groups (p= 0.156). In group III, fibrinogen level (251.64±60.96) was significantly lower than that in groups I (347.97±111.49) and II (364.04±86.20) (p= 0.001).
Hemostatic Parameters
Echocardiographic Findings
TTE was performed in all the stroke patients. Only three patients with NVAF and four patients with sinus rhythm also underwent TEE, because (Table 3 ). There was no correlation between cardiologic findings and stroke severity and hematologic findings.
DISCUSSION
In this study, F1+2 was significantly higher in stroke patients with NVAF than in the healthy subjects and the stroke patients without AF. Fibrinogen levels were significantly higher in the stroke patients with and without NVAF than in the healthy subjects. D-dimer levels were not different among the groups, including the healthy subjects.
Blood coagulation is initiated by tissue factors and tissue factors exposed to circulation after brain infarction and trigger coagulation (10, (16) (17) (18) . As a result, there is a sustained activation of the coagulation system in stroke patients (1) . Stroke mainly occurs in the patients with atrial fibrillation who have low-grade sustained coagulation activation (19) . Thus, activation of coagulation in the acute phase of stroke may reflect a hypercoagulable state before the stroke, as well as the ongoing thrombotic process itself (10) .
It is known that prevalence of NVAF increases with age, and it is an important risk factor for stroke (19) (20) (21) . Left atrial thrombosis causing stroke by arterial embolism has been suggested to be the main pathogenetic mechanism in stroke patients with NVAF (12) . In these patients, coagulation-fibrinolysis abnormalities, endothelial injury, circulatory abnormalities due to increased left atrial diameter, and hypercoagulability contribute to development of cardiac thrombi (22) . That alterations in the hemostatic system are seen in patients with AF contribute to the increased risk of stroke. It was demonstrated that the patients with AF had high F1+2 levels, which reflects in vivo thrombin generation. It was reported that the measurement of F1+2 may identify the patients who are at increased risk for stroke and accelerate patient investigation, which may lead to more effective therapeutic interventions (23) . Gustafsson and colleagues (12) studied several aspects of hemostatic function in stroke patients with and without NVAF to investigate possible disturbances in the blood coagulation and fibrinolytic systems that might increase the risk of stroke among NVAF patients. They founded that stroke patients with NVAF had significantly higher concentrations of fibrinogen and D-dimer than patients with sinus rhythm.
Similar to our study, many studies demonstrated that high levels of the markers of coagulation activation are present in the acute phase of stroke as a result of ongoing coagulation activation (3, 8, 9, (24) (25) (26) . However, in our study, F1+2 was higher in the stroke patients with NVAF than without NVAF. This observation suggested that F1+2 is more sensitive and may show us a difference between the stroke patients with and without NVAF for the degree of coagulation activation during the acute phase. In contrast to F1+2, fibrinogen, which is not a marker of ongoing coagulation, was not different between the stroke patient with NVAF and with sinus rhythm in this study. D-dimer was measured with latex agglutination, a qualitative method, and there was no significant difference among the groups. This result may be explained with quantitative method used in this study.
Berge and colleagues (10) examined the association between hemostatic activation and stroke severity, and provided data of hemostatic variables in acute ischemic stroke and they found that patients with presumed embolic stroke had higher levels of D-dimer, F1+2; the levels of the D-D and F1+2 were related to stroke severity. In our study, the patients with NVAF with the highest F1+2 levels also had TACS+PACS and low Scandinavian Stroke Scale scores, and it was suggested that the activation rate of the hemostatic system may be related to acute stroke severity and perhaps stroke subtype.
Echocardiographic variables as risk factors for stroke in NVAF were investigated by several studies (27) (28) (29) (30) . In patients with left atrial thrombi, the levels of D-dimer were significantly increased in subjects with and without stroke history compared to patients without thrombi. However, there was no significant difference in the levels of D-dimer between the patients with and without spontaneous echo contrast (16, 31) . In our study, there was no correlation between echocardiographic findings and hemostatic variables. This result showed that in the acute phase of the stroke, the finding of associated intracardiac thrombosis cannot produce a significant difference in hemostatic variables.
Acute ischemic stroke patients with NVAF have a higher risk for stroke recurrence than those without NVAF in the first month (32, 33) . Thus, anticoagulant treatment is suggested for these patients in the early period. Despite this, anticoagulants can cause intracranial and extracranial hemorrhage in this period. F1+2 might be beneficial to show which cases have a high recurrence risk for stroke and to show the need for urgent anticoagulant treatment for these cases despite hemorrhage risk.
Consequently, this study showed that F1+2 increases more in stroke patients with NVAF than in the patients with sinus rhythm. Thus, we thought that stroke patients with NVAF should be treated with anticoagulants more intensively than stroke patients with sinus rhythm in the acute period. Moreover, the rate of increase of the F1+2 might be associated with stroke severity.
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